Duquesne Family Office’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-536,900
Closed -$7.79M 91
2024
Q3
$7.79M Buy
+536,900
New +$7.79M 0.26% 53